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cluster biosynthesis uncovers persulﬁde-
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Iron-sulfur (Fe-S) clusters are essential protein cofactors whose biosynthetic defects lead to
severe diseases among which is Friedreich’s ataxia caused by impaired expression of frataxin
(FXN). Fe-S clusters are biosynthesized on the scaffold protein ISCU, with cysteine desul-
furase NFS1 providing sulfur as persulﬁde and ferredoxin FDX2 supplying electrons, in a
process stimulated by FXN but not clearly understood. Here, we report the breakdown of this
process, made possible by removing a zinc ion in ISCU that hinders iron insertion and
promotes non-physiological Fe-S cluster synthesis from free sulﬁde in vitro. By binding zinc-
free ISCU, iron drives persulﬁde uptake from NFS1 and allows persulﬁde reduction into sulﬁde
by FDX2, thereby coordinating sulﬁde production with its availability to generate Fe-S clus-
ters. FXN stimulates the whole process by accelerating persulﬁde transfer. We propose that
this reconstitution recapitulates physiological conditions which provides a model for Fe-S
cluster biosynthesis, clariﬁes the roles of FDX2 and FXN and may help develop Friedreich’s
ataxia therapies.
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Iron-sulfur (Fe-S) clusters are highly conserved and ubiquitousprosthetic groups of proteins, made of iron and sulﬁde (S2−)ions, of which the [2Fe2S] and [4Fe4S] clusters are the most
common in biology1–4. Organisms from the three life kingdoms:
archea, bacteria, and eukaryota have exploited the versatile
properties of Fe-S clusters to perform essential biological func-
tions, including ATP production, Krebs cycle, protein synthesis,
and maintenance of genome integrity5,6. The defects in Fe-S
cluster biosynthesis lead to severe human pathologies, which
underscores the importance to unravel the mechanism of their
assembly2,7–12. Fe-S clusters are biosynthesized de novo by spe-
cialized multi-protein machineries via a process conserved from
bacteria to eukaryotes1,3,4,6,13. In mitochondria, Fe-S clusters are
assembled by the Iron Sulfur Cluster assembly machinery (ISC),
which encompasses the scaffold protein ISCU, the NFS1-ISD11-
ACP complex containing the cysteine desulfurase NFS1, a
pyridoxal-phosphate (PLP) enzyme that generates a precursor of
sulﬁde in the form of a cysteine-bound persulﬁde (Cys-SSH) by
desulfurization of L-cysteine, ferredoxin 2 (FDX2) and its cognate
reductase (FDXR) which together deliver electrons provided by
NADPH and frataxin (FXN) which is required for efﬁcient Fe-S
cluster biogenesis1–4,9. However, how the ISC machinery operates
is not clearly understood and thereby, the biochemical roles of
FDX2 and FXN are not established1,3,9. Fe-S clusters biosynthesis
is thought to rely on conﬁned production of sulﬁde in the
proximity of iron to promote formation of the iron-sulﬁde bond
while preventing toxic diffusion of iron and sulﬁde ions, but no
data have documented such a conﬁned synthesis1,3.
Several reconstitutions of both, bacterial and eukaryotic ISC
machineries have attempted to address these questions14–21.
Bacterial ISC reconstitutions indicate that the homologue of
NFS1, IscS, transfers several persulﬁdes to multiple cysteines on
the ISCU homologue, IscU, which suggests that sulﬁde produc-
tion takes place on the scaffold protein22,23. In mammals too,
persulﬁdes are transferred to ISCU, but only one of its cysteines
becomes persulﬁdated14,24. These reconstitutions have, however,
not answered the question of the physiological reductant of the
persulﬁde and whether its reduction is coupled to the presence of
iron. The FDX2-FDXR reducing system is a good candidate for
this reaction, but most reconstitutions used the non-physiological
reductant dithiothreitol (DTT) instead, thereby occulting the
possible function of FDX2 in this process15,16,18–20. Moreover,
DTT-dependent Fe-S cluster reconstitution cannot be considered
as reproducing a physiological process since DTT reduces the
persulﬁde of the cysteine desulfurase, which leads to formation of
free sulﬁde that is not conﬁned to ISCU14,21. DTT was also shown
to promote formation of [4Fe4S] clusters, the biosynthesis of
which is apparently supported by the ISCA type proteins25–27.
The ﬁrst study of the role of FDX2 was performed with bacterial
Fdx2 and indicated that it promotes reductive coupling of [2Fe2S]
clusters into [4Fe4S], which may not be physiologically relevant
as formation of [4Fe4S] clusters on ISCU is possibly non-
natural17. A FDX2-dependent assembly of [2Fe2S] clusters on
ISCU was then reported with yeast proteins, thus suggesting that
FDX2 is an important component, but evidence that FDX2
reduces the persulﬁde was not provided21. Moreover, we found
that FDX2 is not able to reduce the persulﬁde transferred to
ISCU, which questioned its role in persulﬁde reduction14.
Similarly, the role of frataxin (FXN) remains very controversial
despite tremendous efforts to understand its biochemical func-
tion9. Since the discovery that Friedreich’s ataxia (FA), a severe
neurodegenerative and cardiac disease that is the most common
form of recessive ataxia is caused by defective expression of FXN,
this protein has been the focus of intense research2,9,10,28. FXN
was ﬁrst proposed to operate as an iron chaperone or iron storage
protein providing iron to the ISC machinery, but this model was
challenged by several in vivo studies9,29–31. The reconstitutions of
the ISC machinery with FXN did not provide a clearer picture
either14,15,18,20,32. The ﬁrst reconstitution was performed with the
bacterial system and unexpectedly showed that the bacterial
homolog of FXN, CyaY, inhibits the rate of Fe-S cluster assembly
under iron rich conditions, by slowing down sulﬁde release by
IscS, which was interpreted as a mechanism needed to prevent
uncontrolled Fe-S cluster formation15,32. The reconstitutions of
the mammalian system showed in contrast that FXN stimulates
sulﬁde production and concomitantly iron entry in the ISC
complex14,18,20. However, these studies were performed with
DTT instead of the FDX2-FDXR reducing system, which again
questions their physiological relevance. Another study reported
that yeast FXN stimulates persulﬁde formation on NFS133, but
this could not be reproduced with the murine proteins14. The
only reconstitution including both FDX2 and FXN concluded
that FXN is strictly required for Fe-S cluster assembly, which
may not be consistent with the dispensable role of FXN
in vivo21,31,34–36. FXN was also reported to stimulate persulﬁde
transfer to ISCU, therefore promoting conﬁned production of
sulﬁde14,24. However, FDX2 was unable to reduce the persulﬁde
on ISCU, which prevented a direct correlation with Fe-S cluster
assembly14.
Several studies also attempted to assess the iron binding
properties of ISCU19,37–39. Bacterial IscU was shown to bind iron
in the μM range but another study could not detect interaction
with either Fe2+ or Fe3+ ions19,39. Yeast and drosophila ISCU
proteins were reported to bind iron but not in the assembly site
and it was not shown whether this iron containing form could
sustain Fe-S cluster assembly37,38.
We report here that a clue to these discrepancies is the pre-
sence of a zinc ion in the assembly site of ISCU, which has
been persistently reported in bacterial and eukaryotic ISCU
proteins40–45. We show that this zinc ion hinders iron binding
and precludes the reduction of the persulﬁde of ISCU by FDX2,
thereby fostering reduction of the persulﬁde of NFS1 by
L-cysteine, which leads to release of free sulﬁde and Fe-S cluster
formation that cannot be considered as physiologically relevant
since it is not conﬁned to ISCU. By exchanging zinc with iron, we
generate an iron-loaded ISCU protein allowing Fe-S clusters
synthesis via FDX2-dependent reduction of the persulﬁde of
ISCU. In this process, FXN is not required for iron insertion but
stimulates persulﬁde transfer to ISCU. Moreover, both persulﬁde
transfer and reduction require iron, which most likely ensures the
coordination between sulﬁde production and iron availability in
ISCU. We propose that the reaction performed by iron-loaded
ISCU reproduces the physiological process of Fe-S cluster
assembly, thus allowing the elucidation of the sequence of Fe-S
cluster biosynthesis and the respective roles of FXN and FDX2.
Results
ISCU binds a Fe2+ ion upon removal of the Zn2+ ion. To
address these questions, we ﬁrst attempted to isolate an iron
containing form of ISCU that would be competent for Fe-S
cluster assembly. Analysis of the metal content of puriﬁed mouse
ISCU revealed the presence of zinc as previously reported, but no
iron40–42,46. We measured 0.8 ± 0.1 zinc ion/ISCU and up to 1.0
± 0.1 by incubation with additional zinc (Fig. 1a). Site-directed
mutagenesis conﬁrmed that the conserved amino acids of the Fe-
S cluster assembly site of ISCU, C35, D37, C61, and H103, but not
C104, are required for zinc binding, as also observed in the
structures of human ISCU (Fig. 1a)43. To probe binding of iron to
the assembly site of ISCU, we sought for typical ligand-to-metal
charge transfer (LMCT) bands of ferrous iron bound to cysteine,
expected in the near UV domain47,48. No such feature appeared
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upon addition of Fe2+ to the zinc containing form of ISCU (Zn-
ISCU), alone or in the presence of FXN (Fig. 1b). In contrast,
adding Fe2+ to ISCU devoid of metal (apo-ISCU) produced
absorptions at 270 nm, 310 nm, and 340 nm that are character-
istic of Cys-S→ Fe(II) LMCT bands in the circular dichroism
(CD) spectrum (Fig. 1b). Iron titrations by CD showed that ISCU
binds ~0.95 Fe2+ ions in this site (Fig. 1c, d). Altogether, these
data also show that FXN is not able to exchange zinc for iron and
is neither required for iron insertion in apo-ISCU (Fig. 1b).
Moreover, we did not detect any iron or zinc in puriﬁed FXN,
which strengthened the idea that FXN is not involved in iron
insertion.
We next evaluated the effect of iron on the structure of apo-
ISCU by NMR spectroscopy, since ISCU was reported to exist in
two different conformational states, structured (denoted S) and
disordered (denoted D), and zinc was shown to stabilize the S
state49. The NMR spectrum of apo-ISCU displayed broad central
signals that were assigned to the D state and more dispersed
resonances corresponding to the S state (Supplementary Fig. 1a).
Integration of the tryptophan W74 signals indicated that ~30% of
apo-ISCU was in the S form (inset of Supplementary Fig. 1a).
Upon addition of iron, the central part of the spectrum became
more resolved and additional dispersed signals appeared
(Supplementary Fig. 1b). Two signals were visible for W74: an
intense one slightly shifted relative to that of the S form of apo-
ISCU, and a weak one at the position of the D form of apo-ISCU.
By analogy, we assigned the weak signal to remaining apo-ISCU
in the D form and the shifted intense signal to an iron containing
S form. Integration of the W74 signals indicated that ~80% of
ISCU was in the S state.
To further assess the iron binding properties of ISCU, we used
Mössbauer spectroscopy. The Mössbauer spectrum of apo-ISCU
incubated with one equivalent of Fe2+ revealed the presence of
two species (Fig. 1e, Supplementary Table 1). The parameters of
the major component (component 1, 85%) were indicative of a
high spin Fe(II) center coordinated in a mixed environment by
one or two cysteines and two or three N/O ligands, consistent
with the CD spectrum (Supplementary Tables 1 and 2 and
Supplementary Note 1)50. The high value of the quadrupole
splitting (3.51 mm.s−1), that is growing with asymmetry, is in
agreement with this mixed coordination. Remarkably, the
amount of component 1 was similar to the proportion of ISCU
in the S state, which suggests that binding of iron to this site
promotes conversion of the D to S state. In contrast, the isomeric
shift of the minor species (component 2, 15%) was consistent
with a Fe(II) center coordinated by ﬁve or six N/O atoms but no
sulfur (Supplementary Tables 1 and 2). The parameters of this
species were not identical to those of free iron and this species
was absent when apo-ISCU was incubated with a sub-stoichio-
metric amount of iron, which suggests that component 2 is iron
bound to ISCU in a lower afﬁnity site compared to component 1
(Supplementary Fig. 1c, d and Supplementary Table 1).
To identify the ligands of the iron ion in these sites, we used
site-directed mutagenesis. The C35S, D37A, and C61A substitu-
tion mutants lacked the typical LMCT bands when incubated
with ferrous iron (Fig. 1f). Very weak absorptions were detected
for the H103A mutant but its Mössbauer spectrum lacks the
typical signal of the iron-cysteinyl site (Fig. 1f, Supplementary
Fig. 1e and Supplementary Note 1). In contrast, the C104S
mutant exhibited intense Cys-S→ Fe(II) LMCT absorption bands
and the major species detected by Mössbauer spectroscopy (65%)
displayed parameters nearly identical to those of the WT protein
(Fig. 1f, Supplementary Fig. 1f and Supplementary Note 1). The
lack of the minor species (component 2) in the H103A and C104S
mutants further suggested that H103 is a ligand of this iron ion
and that the C104S mutation impairs iron binding to this site
(Supplementary Note 1). We conclude that the zinc ion prevents
iron binding in the assembly site of ISCU, which may explain the
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NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11470-9 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:3566 | https://doi.org/10.1038/s41467-019-11470-9 | www.nature.com/naturecommunications 3
lack of interaction with iron previously observed38,39. Removing
zinc allows binding of a Fe2+ ion in the assembly site via the C35,
D37, C61, and H103 amino acid residues, which stabilizes the S
state of ISCU. The minor component may correspond to iron
bound in a distorted assembly site via H103 in the D state.
Physiologically relevant assembly of Fe-S cluster by Fe-ISCU.
We then tested the ability of both, Fe-ISCU (apo-ISCU incubated
with one equivalent of Fe2 + ions) and Zn-ISCU in the presence
of one equivalent of iron, to assemble a Fe-S cluster, under
catalytic conditions with all the components of the ISC
machinery (the NFS1-ISD11-ACP (NIA) complex, FXN, FDX2
and FDXR) at a 1:10 molar ratio relative to ISCU, NADPH as a
source of electrons and L-cysteine in stoichiometric amounts
relative to ISCU. Fe-S cluster assembly was monitored by CD
and UV-visible spectroscopies. The reaction with Fe-ISCU led to
appearance of a species within 3 min, with spectroscopic features
identical to those reported for the oxidized form of the [2Fe2S]
cluster in ISCU (Fig. 2a, b)16,21. In contrast, the reaction with
Zn-ISCU generated virtually no Fe-S cluster (Fig. 2a), in agree-
ment with the hindrance of iron binding in the assembly site
when zinc is bound (Fig. 1b). Mössbauer spectroscopy and native
mass spectrometry showed that exclusively [2Fe2S]2+ clusters
were generated, in contrast to previous reconstitutions which
reported formation of both [2Fe2S] and [4Fe4S] clusters (Fig. 2c,
d, Supplementary Fig. 1h, i and Supplementary Note 2)16,18.
Moreover, native mass spectrometry showed that the [2Fe2S]
cluster was hosted in a monomer of ISCU (Fig. 2d). The iden-
tiﬁcation of two different iron binding sites by Mössbauer
spectroscopy further indicated that the [2Fe2S] cluster was in an
asymmetrical arrangement, in agreement with crystal structures
and spectroscopic studies suggesting a three Cys, one Asp mixed
coordination in a monomer of ISCU (Fig. 2c, Supplementary
Note 2)17,45,51,52.
Iron and cysteine titrations showed that approximately two
irons and two cysteines per ISCU were required to form the
[2Fe2S] cluster when starting from apo-ISCU, with yields in the
range of 90% of reconstituted ISCU, which conﬁrms the
stoichiometry of one [2Fe2S] cluster per ISCU (Fig. 2e, f).
Importantly, these data also indicate that the reaction is highly
efﬁcient, with processing of nearly all L-cysteine and iron added
into [2Fe2S] clusters. Similar spectra were collected when the
reaction was performed with stoichiometric amounts of the NIA
complex, ISCU and FXN, which attested that the Fe-S cluster is
generated within the NFS1-ISD11-ACP-ISCU-FXN (NIAUF)
complex (Supplementary Fig. 2a).
We then evaluated the dependence of this reaction on FXN and
FDX2. In reactions missing FDX2, the assembly was compro-
mised, consistent with the absolute cellular requirement of FDX2
for Fe-S cluster biogenesis (Fig. 2g)53,54. When FXN was omitted,
the assembly was slowed down, consistent with the signiﬁcant
decrease of Fe-S cluster biogenesis activity in cells lacking FXN
(Fig. 2g)31,34,35. In conclusion, the reconstituted system with
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Fe-ISCU appears to recapitulate biological conditions of Fe-S
cluster assembly. Furthermore, the reaction performed without
FXN led to formation of a [2Fe2S] cluster with identical features
as those observed in the presence of FXN and in similar yields as
the complete reaction, thus suggesting that FXN does not change
the outcome of the reaction, but only modulates its rate (Fig. 2g,
Supplementary Fig. 2d).
Mechanism of FDX2-based Fe-S cluster assembly by Fe-ISCU.
We next examined how the persulﬁde of NFS1 was reduced and
sulﬁde incorporated as a Fe-S cluster. We previously showed
using a protein persulﬁdation assay that NFS1 transfers its per-
sulﬁde to the cysteine C104 of ISCU14. Using this assay, we
monitored persulﬁde transfer to Fe-ISCU and Zn-ISCU and
found that both acquire a persulﬁde from NFS1, on a single
cysteine (Fig. 3a). Lack of transfer with the C104S mutant pro-
vided evidence that this residue serves as the persulﬁde receptor,
and mass spectrometry indicated that a single sulfur atom is
incorporated in ISCU (Fig. 3b–d)14. In the absence of metal,
persulﬁde transfer was abolished (Fig. 3b), despite formation of a
complex between apo-ISCU, FXN, and the NIA complex (Sup-
plementary Fig. 3a and Supplementary Note 3), which indicates
that the metal ion is required for persulﬁde transfer. Adding
FDX2 to the persulﬁdated form of Fe-ISCU led to disappearance
of the persulﬁde and concomitant formation of a Fe-S cluster,
thus indicating that FDX2 reduces the persulﬁde into sulﬁde
(Fig. 3a left panel, 3e, 3f). In contrast, FDX2 was unable to
reduce the persulﬁde of Zn-ISCU, which explains the inability of
this form to assemble a Fe-S cluster (Fig. 3a right panel). Per-
sulﬁde reduction was also precluded in the absence of metal,
which rules out the idea that zinc could be inhibitory and instead
points to a speciﬁc requirement of iron for persulﬁde reduction
(Fig. 3g).
Since formation of a [2Fe2S] cluster requires two sulﬁdes, we
asked whether a second sulﬁde was provided by NFS1 either
directly, by FDX2-mediated reduction of the persulﬁde of NFS1,
or indirectly, via a second transfer-reduction process following
reduction of the ﬁrst one. In both cases, a concomitant
disappearance of the persulﬁdes of NFS1 and ISCU was expected
upon addition of FDX2. To prevent reloading of NFS1 with a
persulﬁde, which would otherwise mask both direct reduction
and second transfer, we used sub-stoichiometric amounts of L-
cysteine. These experiments were performed by incubating
reaction mixtures containing the NFS1-Fe-ISCU complex with
various amounts of L-cysteine from sub-stoichiometric to
excess, prior to adding FDX2. The persulﬁdation states of
NFS1 and ISCU were analyzed before and after addition of
FDX2. Upon addition of FDX2, the persulﬁde of ISCU was
reduced as described in the previous section, but the persulﬁde
of NFS1 did not disappear, thus establishing that only
one sulﬁde is provided to ISCU (Fig. 3h, i). As ISCU binds
only one iron ion, formation of a [2Fe2S] cluster likely requires
dimerization of ISCU followed by segregation of the Fe-S cluster
on one of the two subunits.
FXN stimulates persulﬁde transfer to Fe-ISCU. We next
inspected the effect of FXN on each step of the assembly process.
The yeast FXN homologue was proposed to stimulate persulﬁde
formation on NFS133. However, this effect could not be observed
with the murine system, therefore indicating that FXN operates at a
later step14. We ﬁrst tested the effect of FXN on persulﬁde transfer.
We previously reported that persulﬁde formation on NFS1 is much
faster than persulﬁde transfer, i.e., that persulﬁde transfer is the
rate-limiting step of this process14. Thereby, the global rate of
persulﬁdation of ISCU upon addition of L-cysteine to the NIAU
complex, which encompasses both, persulﬁde formation on NFS1
and its transfer to ISCU, only reﬂects persulﬁde transfer, thus
allowing direct determination of the rate of persulﬁde transfer by
measuring the rate of the two-step reaction. In the absence of FXN,
persulﬁde transfer still occured and was completed in about 30min
(Fig. 4a, upper panel). In the presence of FXN, the rate of the
reaction was markedly increased, with a transfer nearly complete in
5min (Fig. 4a, lower panel). The same effect was observed with Zn-
ISCU, consistent with our previous observation with as-puriﬁed
ISCU (Fig. 4b)14. Since the rates of persulﬁdation of Fe-ISCU and
Zn-ISCU are both much lower than the previously reported rate of
persulﬁde formation on NFS1, persulﬁde transfer appears rate-
limiting here too. Therefore, the effects of FXN on the rates of
persulﬁdation of Fe-ISCU and Zn-ISCU indicate that FXN stimu-
lates persulﬁde transfer in both cases. In contrast, FXN did not
affect the rate of persulﬁde reduction (Fig. 4c).
Overall, these data suggest that FXN modulates the rate of Fe-S
cluster assembly by acting solely on the persulﬁde transfer step,
which is mechanistically feasible only if persulﬁde transfer is the
rate-limiting step of the whole process. We thus compared the rate
constants of persulﬁde transfer determined by the alkylation assays
(Fig. 4a, d) with those of (i) persulﬁde reduction by FDX2 that is
combined with formation of the [2Fe2S] cluster and determined by
monitoring Fe-S cluster formation upon addition of FDX2 to a
persulﬁdated form of the NIAU complex (Fig. 4c), and (ii) the
global reaction of Fe-S cluster assembly monitored by UV-visible
spectroscopy upon addition of L-cysteine (Fig. 4e), using stoichio-
metric amounts of the NFS1-ISD11-ACP complex and Fe-ISCU.
The values of the rate constants of persulﬁde transfer and Fe-S
cluster assembly were comparable, both in the presence and absence
of FXN, and much lower than the rate constant of persulﬁde
reduction by FDX2, thus indicating that persulﬁde transfer is the
rate-limiting step of the whole process (Fig. 4d–f). This provides
evidence that FXN stimulates Fe-S cluster biosynthesis by
accelerating persulﬁde transfer to Fe-ISCU.
Zn-ISCU promotes Fe-S cluster synthesis from free sulﬁde. We
showed above that Zn-ISCU cannot assemble a Fe-S cluster when
incubated with one equivalent of iron and L-cysteine. However,
Fe-S cluster reconstitutions with as-puriﬁed ISCU which pre-
sumably contained zinc, were previously reported14–16,18,20,21.
We indeed observed reconstitution of a Fe-S cluster by Zn-ISCU
in the presence of iron, but only when the concentration of L-
cysteine was raised above stoichiometry (Fig. 5a). The spectro-
scopic features of the Fe-S cluster generated by Zn-ISCU were
identical to those of the [2Fe2S] cluster reconstituted by Fe-ISCU
(Fig. 5b). Moreover, the rate of the reaction was slowed down in
the absence of FXN, as reported for the reconstitutions performed
with as-puriﬁed ISCU (Fig. 5c)14,18,20. This suggests that this
reaction reproduces the phenotype of cells lacking FXN. How-
ever, this reaction was about 50 times slower relative to the
reaction with Fe-ISCU and required about 30 times more L-
cysteine to reach the same yield in Fe-S clusters, which accounted
for only 5% of L-cysteine incorporated (Fig. 5a). Furthermore, in
the absence of FDX2, the reaction was only slowed down, not
abolished, which suggests that this reaction does not reproduce
the physiology since FDX2 is essential for Fe-S cluster biogenesis
in vivo (Fig. 5c)53,54.
We thus examined the mechanism of the reaction performed by
Zn-ISCU. Since the persulﬁde of ISCU is not reducible in the
presence of zinc (Fig. 3a), the origin of sulﬁde was likely NFS1. In
the absence of FDX2, Fe-S clusters were still formed, which
indicated that FDX2 is not the main reductant in this reaction
(Fig. 5c). Instead, the dependency of the rate of the reaction on the
concentration of L-cysteine suggests that L-cysteine is the
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reductant (Fig. 5a). This assumption is corroborated, on one hand,
by our previous data demonstrating that L-cysteine is able to
reduce the persulﬁde of NFS1, a reaction which generates free
sulﬁde through intermediate formation of persulﬁdated L-cysteine,
and is stimulated by FXN, and, on the other hand, by the sigmoidal
behavior observed in the absence of FDX2 that is a hallmark of the
accumulation of an intermediate species (Fig. 5c)14. We thus
propose that the poorly efﬁcient Fe-S cluster assembly reaction
performed by Zn-ISCU proceeds via formation of free sulﬁde and
is stimulated by FXN at the stage of sulfur transfer to L-cysteine, as
previously reported with as-puriﬁed ISCU14.
Discussion
We show here that upon removal of its zinc ion, ISCU can bind a
Fe2+ ion in the assembly site and carry out Fe-S cluster assembly
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with high efﬁciency, as virtually all iron and L-cysteine are
incorporated in the form of [2Fe2S] clusters. Our step-by-step
analysis indicates that the mechanism of assembly relies on the
transfer of the persulﬁde of NFS1 to ISCU that is subsequently
reduced into sulﬁde by FDX2, leading to formation of a [2Fe2S]
cluster in a monomer of ISCU (Fig. 6). These data thus provide
evidence that FDX2 operates in persulﬁde reduction and is
essential since Fe-S cluster assembly was compromised in its
absence. Our data also provide information on the nucleation
process leading to a dinuclear [2Fe2S] cluster. As only one iron is
initially present in ISCU and only one sulﬁde ion is generated per
ISCU by FDX2, we postulate that formation of the Fe-S cluster
requires dimerization of ISCU to generate a bridged [2Fe2S]
cluster at the interface of the two subunits, which then segregates
on one of the two monomers. Two structures of the NFS1-ISD11-
ACP complex were reported which both displayed a dimeric
complex but with distinct topologies43,44. In the structure
reported by Boniecki et al., the two ISCU proteins are bound at
the opposite ends of the complex thus precluding dimerization43.
Whereas in the structure reported by Cory et al., although it does
not contain ISCU, modelling predicts that the two ISCU proteins
are very close to each other, thus consistent with formation of a
dimer within the complex44.
Our data also indicate that a key feature of the Fe-ISCU based
reaction is the iron-dependency of both persulﬁde transfer and
reduction, which most likely ensure that sulfur transfer and sul-
ﬁde production are coordinated with iron availability in ISCU,
thereby preventing futile persulﬁde transfer cycles and allowing
instantaneous binding of the nascent sulﬁde to the nearby iron.
Strikingly, zinc and iron appear interchangeable for persulﬁde
transfer. The metal ion might function as a Lewis acid creating an
electrophilic character on the sulfane sulfur of the persulﬁde of
NFS1 to facilitate the nucleophilic attack by the receptor cysteine
of ISCU. In contrast, persulﬁde reduction by FDX2 is operative
with iron, but precluded with zinc. During assembly, the iron ion
switches from the+2 state in Fe-ISCU to the+3 state in the
[2Fe2S]. This suggests that the iron ion is the source of one of the
two electrons needed for persulﬁde reduction, with the other one
being donated by the [2Fe2S] cluster of FDX2. This could explain
why reduction does not occur on Zn-ISCU.
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This model contrasts with the one drawn from the data
obtained with Zn-ISCU (Fig. 6). When zinc is in the assembly
site, the impeded reduction of the persulﬁde of ISCU by FDX2
fosters the reduction of the persulﬁde of NFS1 by L-cysteine,
which leads to formation of persulﬁdated L-cysteine (Cys-SSH)
that is decomposed into sulﬁde by another molecule of L-cysteine,
as previously described with as-puriﬁed ISCU14. FDX2 also
promotes this reaction most likely by reducing Cys-SSH. The
sulﬁde ions then combine with iron to form a Fe-S cluster that is
inserted in ISCU in a poorly efﬁcient way akin to chemical
reconstitution1,14. This reaction might only occur in vitro, as
in vivo, the persulﬁdated cysteine and the sulﬁde ions will not
remain in ISCU but will diffuse throughout the cell. Moreover,
the zinc ion was shown to decrease the rate of sulﬁde production
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which may help mitigate this side-effect in vivo46. We thus
propose that the Fe-ISCU based reconstitution is the one that
recapitulates the physiological Fe-S cluster assembly process.
Since the presence of zinc has been persistently reported in
eukaryotic and prokaryotic recombinant ISCU proteins, we pre-
sume that all previous Fe-S cluster reconstitutions were describ-
ing the non-physiological Fe-S cluster assembly process.
Nevertheless, although the zinc ion hinders physiologically rele-
vant Fe-S cluster assembly on ISCU, by enabling persulﬁde
transfer to ISCU and by preventing reduction by FDX2, it might
convert ISCU into a sulfur-transferase as proposed for the
Bacillus subtilis SufU protein, a closely related homolog of
ISCU55.
Our data indicate that the function of FXN is to accelerate
persulﬁde transfer to Fe-ISCU that is the rate-limiting step of Fe-
S cluster synthesis. Further, the effect of FXN, as it does not
modify the nature of the Fe-S cluster formed on ISCU and its
yield, points to a regulatory function, which ﬁts to FXN non-
essential role in vivo31,34–36. FXN also enhances persulﬁde
transfer to Zn-ISCU, as previously reported with as-puriﬁed
ISCU14, which might be linked to the above-proposed sulfur-
transferase function of Zn-ISCU. FXN thus appears as an
enhancer of metal-dependent persulﬁde transfer reactions. It may
operate by either promoting persulﬁde binding to the metal
center, by modifying the coordination sphere of the metal ion or
by deprotonating the receptor cysteine of ISCU to increase its
nucleophilic ability. Addressing these questions will be critical to
understand the biochemical function of FXN.
A reconstitution of the yeast ISC machinery that included
FDX2, reported that FXN is critical for Fe-S cluster synthesis, a
conclusion not supported by our data21. In these experiments, a
signiﬁcant amount of Fe-S cluster (30%) was still formed in the
absence of FDX2, and also in reactions lacking FXN, which are in
fact typical features of the Zn-ISCU-based reaction (Fig. 5c).
Therefore these data might not be used to draw any conclusions
on the physiological role of FXN in Fe-S cluster biosynthesis.
FXN was also proposed to deliver iron to the ISC machinery
based on its ability to bind iron. However, this hypothesis has
been questioned by several studies9,29,36. Anyhow, if indeed FXN
carries this additional function, then how would zinc be
exchanged? This would require another enzyme since FXN is not
able to exchange zinc for iron. Our data instead indicate that FXN
does not bind iron and is not required for iron insertion.
Therefore, its biochemical role seems to be restricted to the sti-
mulation of persulﬁde transfer.
Altogether, our data afford evidence that FXN operates in Fe-S
cluster biogenesis as a kinetic activator of persulﬁde transfer, a
function that probably is conserved in prokaryotes given the
homologies of prokaryotic and eukaryotic frataxin proteins. Such
a regulatory function further suggests that the expression of FXN
is tightly regulated in order to adapt Fe-S cluster biogenesis to the
cellular demand. Our results thus open perspectives to unravel
the pivotal role of FXN in Fe-S cluster biogenesis that will help
better understand the pathophysiology of FRDA and research in
the development of therapeutic treatments9.
Methods
Chemicals and materials. Luria Bertani medium, protease inhibitor cocktail
(sigmafast), sodium phosphate dibasic (Na2HPO4), urea, tris base, tris HCl, sodium
dodecyl sulfate (SDS), dithiothreitol (DTT), L-cysteine, nicotinamide adenine
dinucleotide phosphate (NADPH), human His6-thrombin, Ethylenediamine tet-
raacetic acid (EDTA), diethylene triamine pentaacetic acid (DTPA), isopropyl β-D-
1-thiogalactopyranoside (IPTG), ferrous ammonium sulfate (Fe(NH4)2(SO4)2),
imidazole, zinc sulfate (ZnSO4), 4-(2-pyridylazo)resorcinol (PAR), 3-(2-pyridyl)-
5,6-diphenyl-1,2,4-triazine-p,p′-disulfonic acid monosodium salt hydrate (Ferro-
zine), ascorbic acid and acrylamide:bis-acrylamide (29:1) solutions were from
Sigma–Aldrich. HiTrap chelating HP column (5 ml), PD-10 desalting, HiPrep
Desalting 26/10, HiLoad 16/60 prep grade Superdex 200 and Superdex 75 columns
were from GE Healthcare; Amicon Ultra centrifugal ﬁlter ultracel 10 and 30 kDa
from MILLIPORE, MicroBio-Spin columns from Bio-Rad; Rosetta2-(DE3) and
pET28b from Novagen, cuvette from Hellma
Protein puriﬁcation. The vectors expressing NFS1-(amino acid (aa) 59–459),
ISD11, ISCU-(aa 36–168) and FXN-(aa 79–207) were kindly provided by Dr.
Hélène Puccio (IGBMC, Strasbourg). His-tags followed by thrombin (Thr) cleavage
sites were introduced by mutagenesis leading to the expression plasmids
pCDFDuet-site1: 6xHis-Thr-NFS1-site2:ISD11, pETDuet-site1: 6xHis-Thr-ISCU
and pET16-6xHis-Thr-FXN. The C35S, D37A, C61A, C96S, H103A, and C104S
mutations were introduced in ISCU by site-directed mutagenesis (IMAGIF plat-
form, Gif Sur Yvette, France). The vectors expressing human 6xHis-Thr-FDX2
(aa53-183) from pET28b was generated by GenScript (Piscataway, USA). The
Rosetta2-(DE3) cells were transformed with the plasmids and the cells were grown
from a single colony at 180 rpm at 37 °C in LB with appropriate antibiotics. Protein
expression was induced when the cells reached OD600= 0.6 using 500 μM IPTG
and the cells incubated for an additional 16 h at 18 °C at 180 rpm for the expression
of NFS1-ISD11 and 3 h at 30 °C for the expression of ISCU, FXN, and FDX2. The
cell cultures were harvested by centrifugation at 5500 rpm for 10 min at 4 °C. Cell
pellets were resuspended in buffer A (50 mM Na2HPO4, 150 mM NaCl, 5 mM
imidazole, pH 8) containing a protease inhibitor cocktail. The cell suspensions were
lysed by 3 cycles of French Press. Cell debris were removed by centrifugation at
45,000 rpm for 45 min at 4 °C. The His-tagged proteins NFS1-ISD11-ACP, ISCU
(WT and mutants), FXN, and FDX2 were puriﬁed on a HiTrap chelating HP
loaded with nickel ions. The resin was washed with buffer A and bound proteins
were eluted by a linear gradient of buffer B (50 mM Na2HPO4, 150 mM NaCl,
500 mM imidazole, pH 8). Protein fractions were mixed and concentrated on
Amicon to 4 mL. The His6-NFS1-ISD11-ACP complex was incubated for 10 min
with 10 mM DTT at room temperature to remove persulﬁde and then loaded on a
HiLoad 26/600 Superdex 200 prep grade column pre-equilibrated with buffer P
(50 mM Na2HPO4, 150 mM NaCl, pH 8). The ISCU (WT and mutants), FXN, and
FDX2 proteins were desalted in buffer P on HiPrep Desalting 26/10 and the His-
tags were removed by treatment with thrombin (3.5 NIH unit of His6-thrombin
per mg of proteins) for 16 h at 22 °C. The ISCU proteins (WT and mutants) were
incubated with 10 mM DTT for 10 min to remove persulﬁde. The cleaved ISCU
(WT and mutants), FXN and FDX2 proteins were loaded on a HiLoad 26/600
Superdex 75 prep grade column pre-equilibrated with buffer P. All the proteins
were aliquoted and stored in glycerol (10% ﬁnal) at −80 °C. All these procedures
were also previously described14. For 15N- labeled and 13C,15N-labeled ISCU, ISCU
overexpressing cells were grown in M9 minimal media supplemented with
15NH4Cl (1 g.L−1), glucose (4.g L−1) or 13C-glucose (2.7 g.L−1), ampicillin (100 µg.
mL−1), chloramphenicol (34 µg.mL−1), MgSO4 (2 mM), CaCl2 (50 µM), and ZnCl2
(50 µM). Puriﬁed human FDXR was provided by R. Lill (Marburg). Protein con-
centrations were determined by UV-visible at 278 nm in urea 8M, Tris 0.1 M, pH
= 7.5 using absorption coefﬁcients of 49965, 9700, 26335, 13850, and 44330M−1.
cm−1 for the NFS1-ISD11-ACP complex, ISCU, FXN, FDX2, and FDXR. The
absorption of the PLP (ε= 5000M−1.cm−1) was also used to double-check the
concentration of the NFS1-ISD11-ACP complex.
Metal insertion and exchange. Zn-ISCU was prepared by incubating as-puriﬁed
ISCU with 2 molar equivalents of ZnSO4 followed by desalting to remove excess
zinc. All iron binding properties on Zn-ISCU and preparation of Fe-ISCU were
performed under anaerobic conditions using a Jacomex glove box (O2 < 2 ppm).
Samples were prepared by mixing 2 μL of ferrous ammonium sulfate (5 mM)
prepared in H2O with Zn-ISCU (100 μM), with or without FXN (100 μM) in buffer
P. To prepare Fe-ISCU, the zinc ion was ﬁrst removed by incubating Zn-ISCU with
DTPA, followed by desalting on Superdex to remove excess DTPA. Then apo-
ISCU was incubated with ferrous ammonium sulfate in various conditions as
described in each section. Apo-ISCU incubated with one equivalent of ferrous
ammonium sulfate is denoted Fe-ISCU thereafter.
Fe-S cluster assembly assays. Fe-S cluster assembly assays were performed under
anaerobiosis in two different conditions: catalytic and stoichiometric. Standard
catalytic conditions included Zn-ISCU (100 μM) incubated with one molar
equivalent of ferrous ammonium sulfate or Fe-ISCU (100 μM), mixed with the
NFS1-ISD11-ACP complex (10 µM), FXN (10 µM), FDX2 (10 µM), FDXR (1 µM),
and NADPH (200 μM) in buffer P. The mix was transferred into a septum sealed
cuvette and the reaction was initiated with L-cysteine (100 µM) introduced with a
gastight Hamilton syringe. The kinetics of assembly were monitored by UV-visible
spectroscopy at 456 nm. The kinetics of Fe-S cluster assembly with Zn-ISCU at
high L-cysteine concentrations were monitored by CD at 430 nm as promiscuous
Fe-S clusters were reported to be formed that could contribute to the absorption by
UV-visible but not to CD26. Standard stoichiometric conditions included Fe-
ISCU (100 μM), the NFS1-ISD11-ACP complex (100 µM), FXN (100 µM), FDX2
(10 µM), FDXR (1 µM), and NADPH (200 μM) in buffer P. The reactions were
initiated by L-cysteine (100 µM) as described for catalytic conditions.
To assess the effect of FXN on the reduction of persulﬁde by FDX2, the reaction
of persulﬁdation of ISCU was performed using stoichiometric amounts of Fe-ISCU
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(50 μM) and the NFS1-ISD11-ACP complex (50 µM) with 1 equivalent of L-
cysteine for 30 min in buffer P, then FDX2 (5 µM), FDXR (1 µM) and NADPH
(100 μM) with or without FXN (50 μM) were added and the reaction of Fe-S cluster
assembly was monitored at 456 nm by UV-visible spectroscopy.
UV-visible and CD spectroscopies. Electronic absorption spectra in the UV-
visible domain were acquired using a Secomam UVIKON XL spectrometer and CD
spectra using a Jasco J-815 CD spectrometer. For iron binding properties of Zn-
ISCU, the samples were prepared by mixing 2 μL of ferrous ammonium sulfate
(5 mM) prepared in H2O with Zn-ISCU (100 μM), with or without FXN (100 μM)
in buffer P and under anaerobic conditions. For iron binding properties of apo-
ISCU, the samples were prepared by mixing apo-ISCU (100 μM), WT and mutants
(C35S, D37A, C61S, H103A that are devoid of zinc, and apo-C104S) prepared in
buffer P with 2 μL of ferrous ammonium sulfate (5 mM) prepared in water. The
mixtures were then introduced in a septum sealed cuvette.
To generate UV-visible and CD spectra of reconstituted ISCU alone and in the
NIAUF complex the contribution of the proteins and non-incorporated
component was subtracted. To this end, the mixture at the end of the reaction was
desalted on a Biospin P6 column to remove the contribution of non-incorporated
components, essentially NADPH, and the UV-visible and CD spectra were
collected. Then the contribution of the proteins was removed by subtraction of the
spectra of the initial mixture (minus L-cysteine and NADPH). To account for
protein loss during the desalting procedure, the amount of the initial spectra to be
subtracted was calculated based on total protein concentration measured by the
Bradford method before and after desalting. Scales in molar absorption coefﬁcients
referred to the absorption coefﬁcients of the [2Fe2S] clusters of free ISCU and of
ISCU in the NIAUF complex (see quantiﬁcations section).
Quantiﬁcations of zinc, iron, and Fe-S clusters. The zinc content of ISCU was
measured by inductively coupled plasma mass spectrometry (ICP-MS) at IRAMIS,
CEA Saclay, France, and routinely by a colorimetric method using 4-(2-pyridylazo)
resorcinol (PAR), a metallochromic indicator. In brief, a standard curve at 500 nm
was prepared using zinc sulfate in the 0–10 μM range in 8 M urea, 150 mM Tris,
pH 7.5 containing 100 μM of PAR. The amount of zinc in the proteins was
measured in the same buffer for ﬁve different concentrations. Iron in proteins was
quantiﬁed by ICP-MS. Routinely, the concentration of iron in stock solution was
determined using ferrozine56.
Fe-S clusters were quantiﬁed routinely by UV-visible spectroscopy based on
absorption coefﬁcients that were determined by quantiﬁcation of iron by ICP-MS.
To determine the absorption coefﬁcient of the [2Fe2S] cluster of free ISCU and
ISCU within the NIAUF complex, ISCU was reconstituted under catalytic and
stoichiometric conditions, respectively, with 2 eq. of iron and L-cysteine to reach
the maximum yield. For free ISCU, the proteins were separated on a Superdex 75
column under anaerobic conditions. The fractions corresponding to monomeric
free ISCU holding a Fe-S cluster were pooled and a UV-visible spectrum was
collected. Total iron in this sample was measured by ICP-MS. Based on iron
titrations, an absorption coefﬁcient of 7200M−1.cm−1 was determined at 456 nm
for the [2Fe2S] of free ISCU. For ISCU in the NIAUF complex, the reaction
mixture was desalted on a NAP-5 column, a UV-visible spectrum was collected and
total iron was measured by ICP-MS. Since FDX2 was present in this sample which
contains a [2Fe2S] cluster, its contribution to total iron was subtracted based on its
initial concentration. But to account for FDX2 loss during the desalting procedure,
the initial amount of FDX2 was corrected by measuring total protein concentration
by the Bradford method, before and after desalting. The titration of iron, corrected
from the contribution from FDX2, yielded an absorption coefﬁcient of 6000M−1.
cm−1 at 456 nm for the [2Fe2S] of ISCU in the NIAUF complex.
For titration of Fe-S clusters by iron and L-cysteine, the reconstitutions were
performed under catalytic conditions with apo-ISCU (50 μM) mixed with the
NFS1-ISD11-ACP complex (5 µM), FXN (5 µM), FDX2 (5 µM), FDXR (1 µM) and
NADPH (100 μM) in buffer P and various amounts of iron or L-cysteine as
indicated in the text, keeping the concentration of L-cysteine or iron, respectively,
constant at 2 molar equivalents.
Mössbauer spectroscopy. Samples for Mössbauer spectroscopy were prepared by
mixing 300 μL of apo-ISCU (2 mM) WT and mutants, prepared in 50 mM Tris,
150 mM NaCl, pH= 8 (buffer T), with one equivalent of 57Fe enriched solution of
ferrous ammonium sulfate (81.5 mM) prepared in H2O. Samples of ISCU recon-
stituted with a Fe-S cluster were prepared under catalytic conditions with a mixture
containing 350 μL of apo-ISCU (1 mM), 57Fe enriched ferrous ammonium sulfate
(2 mM), the NFS1-ISD11-ACP complex (5 µM), FXN (5 µM), FDX2 (5 µM), FDXR
(1 µM), NADPH (2mM), and L-cysteine (2 mM) in buffer P and after 60 min of
reaction the mixture was desalted. The samples were introduced in sample holders
and frozen in the glove box.
Transmission Mössbauer spectra were recorded with a conventional Mössbauer
spectrometer operated in the constant acceleration mode in conjunction with a
512-channel analyzer in the time-scale mode (WissEl GmbH). The Mössbauer
spectra were calibrated using α-iron foil at room temperature. A continuous ﬂow
cryostat (OptistatDN, Oxford Instruments) was used to cool the samples to 77 K.
Field-dependent conventional Mössbauer spectra were obtained with a helium
closed-cycle cryostat (CRYO Industries of America, Inc.) equipped with a
superconducting magnet. The magnetic ﬁeld was aligned parallel to the γ-ray
beam. The spectral data were transferred from the multi-channel analyzer to a PC
for further analysis employing the public domain program Vinda running on an
Excel 2003® platform57. The spectra were analyzed by least-squares ﬁts using
Lorentzian line shapes with the linewidth Γ. Field-dependent spectra were
simulated by means of the spin Hamilton formalism58.
Denaturing and native mass spectrometry analysis. Nanoelectrospray ioniza-
tion mass spectrometry (nanoESI-MS) analyses were carried out on a quadrupole
time of ﬂight mass spectrometer (Synapt G2 HDMS, Waters) equipped with an
automated chip-based electrospray ionization technology (Triversa Nanomate,
Advion) using the positive ion mode.
Prior to mass spectrometry analysis, the samples were buffer exchanged with
10 mM ammonium acetate (AcONH4) at pH 7.0 using microcentrifuge gel-
ﬁltration columns (Zeba 0.5 mL, Thermo Scientiﬁc).
For denaturing MS analysis, the external calibration was performed using a
2 μM denaturated horse heart myoglobin solution as a standard for denaturing
analysis in the 500–5000m/z range mass spectra. Data acquisition time and scan
time were set at 2-min and 4-s, respectively. Buffer exchanged samples were diluted
to 10 μM in a mixture of water:acetonitrile (1:1) acidiﬁed with 1% of formic acid.
Denaturing MS analyses were performed with an accelerating voltage of 40 V and
the backing pressure of the instrument was ﬁxed to 1.7 mbar. Mass spectra were
deconvoluted with MassLynx 4.1 (Waters, Manchester, UK) using the MaxEnt
module 1 with the following parameters: m/z range: 600–3000; Gaussian
smoothing: 2; mass range: 14,500–15,000 Da, number of iterations: 30; substract:
20–40%.
For native mass spectrometry analysis, cesium iodide cluster ions from a 2 g/L
isopropanol:water (1:1) solution were used to calibrate the mass spectrometer up to
6000m/z. Samples were diluted to 10 μM in 10 mM ammonium acetate (AcONH4)
at pH 7.0. Data acquisition time and scan time were set at 2-min and 4-s,
respectively. To avoid the dissociation of the iron-sulfur cluster protein interaction,
the analysis under native conditions were performed with an accelerating voltage of
40 V and the backing pressure of the instrument was ﬁxed to 6 mbar. Raw data
mass spectra were acquired with MassLynx 4.1 (Waters, Manchester, UK) and
treated with the following parameters: m/z range: 1500-4000; Gaussian
smoothing: 10.
NMR spectroscopy. 1D 1H and 2D 1H-15N SOFAST-HMQC NMR spectra of
unlabeled ISCU and 15N-ISCU were recorded on a Bruker Avance III 800MHz
NMR spectrometer equipped with a TCI cryoprobe at a temperature of 293 K.
Samples were in buffer P containing 7% 2H2O to lock the magnetic ﬁeld. ISCU
concentration was 50–100 µM. Mixed samples with NFS1-ISD11-ACP and FXN
were obtained by adding 1 equivalent of each protein and concentrating the
mixtures to 50 µM ﬁnal concentration. Apo-ISCU and Fe-ISCU samples were in
buffer T and measured in a valved tube ﬁlled in a glove box. Fe-ISCU was prepared
by incubating apo-ISCU with one molar equivalent of Fe2+. The ratio of the S to D
form was estimated based on the intensities of the two Hε-Nε correlation signals of
the tryptophan side chain of ISCU (denoted 74Wε)49.
Maleimide-peptide alkylation assay. Proteins were assayed for persulﬁde by
alkylation with MalP1614. The assays were routinely conducted with stoichiometric
amounts of NFS1-ISD11-ACP, ISCU (WT and mutants, with and without 1
equivalent of metal) and FXN at a ﬁnal concentration of 20 μM and 5 equivalents
of L-cysteine. The reactions were stopped by incubation with 2 molar equivalents
of MalP16 with regard to the total concentration of thiols, under denaturing con-
ditions (2% SDS) for 30 min; then DTT (1 mM) was added and the reactions were
incubated for another 30 min before analysis by SDS-PAGE under reducing con-
ditions. Persulﬁdation of ISCU and NFS1 was monitored on 14% and 10% SDS-
PAGE gels, respectively.
Persulﬁde transfer to Fe-ISCU, Zn-ISCU, apo-ISCU, and the C104S mutant
reconstituted with iron (Fe-ISCUC104S) were assayed in the presence of FXN by
incubating the proteins with the NIA complex and L-cysteine for 5 min. To assay
reduction by FDX2, the persulﬁdated forms of Fe-ISCU and Zn-ISCU were
incubated with FDX2 (20 µM), FDXR (5 µM), and NADPH (100 μM) for 5 min
before analysis by the alkylation assay. To circumvent the co-migration of
alkylated FDX2 with fully alkylated ISCU which corresponds to its non-
persulﬁdated form, a mutant of ISCU lacking the cysteine residue C96, that is
non-conserved, was used to decrease the number of alkylation sites and thereby
decrease the size of alkylated ISCU. We have checked that the C96S mutation
was silent by assessing the kinetics of Fe-S cluster assembly under catalytic
conditions and by comparing the UV-visible spectra with WT ISCU (See
Supplementary Fig. 5a, b). To assess the effect of iron on persulﬁde reduction,
the persulﬁdated form of ISCU prepared as described above was incubated with
DTPA (100 μM) for 10 min before adding FDX2 (20 µM), FDXR (5 µM), and
NADPH (100 μM). We checked by UV-visible that at this concentration of
DTPA the [2Fe2S] cluster of FDX2 was not destroyed and was still reducible by
FDXR and NADPH (See Supplementary Fig. 5c). To assess the parallel effect of
FDX2 on the persulﬁdation of both NFS1 and ISCU (i.e., second transfer or
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direct reduction), WT Fe-ISCU (50 µM), the NIA complex (50 µM), and FXN
(50 µM) were incubated for 10 min with various amounts of L-cysteine, ranging
from sub-stoichiometric to excess, as indicated in the text. Then a mixture
containing FDX2 (5 µM), FDXR (1 µM), and NADPH (50 μM) was added and
the mixture was incubated for 10 min before analysis by the alkylation assay. The
persulﬁdation of both, ISCU and NFS1, before and after adding FDX2, were
analyzed in parallel.
To assess the effect of FXN on the kinetics of persulﬁde transfer, the reactions
were initiated by incubating Zn-ISCU or Fe-ISCU (20 μM) and the NIA complex
(20 μM) with 5 equivalents of L-cysteine in the absence or presence of FXN (20
μM). The reactions were analyzed at different time points by adding the mixture
containing MalP16 and SDS, as described above, to quench the reaction. Then the
persulﬁdation of ISCU was analyzed as described above.
Simulation of kinetics. The kinetics were ﬁtted using the enzyme-substrate model
developed by Michaelis and Menten.
For catalytic conditions of reconstitution, the quasi-stationary state
approximation as developed by Briggs and Haldane was applied to the linear
portion of the kinetics corresponding to the steady state conditions. In this model
the initial and maximum velocities, Vi and Vmax, are express as follows:
Vi ¼
dP
dt
¼ Vmax  S0½ 
S0½  þ KM
ð1Þ
Vmax ¼ k2  E0½  ð2Þ
Where P is the concentration of product, [S0] and [E0] are the initial concentrations
of substrate and enzyme, respectively, KM is the Michaelis constant and k2 the rate
of product formation. As the initial velocities were constant at all concentrations of
L-cysteine tested (Supplementary Fig. 2b), this indicated that the rate of the
reaction was at its maximum velocity. The initial velocity could then be equal to the
maximum velocity:
Vi ¼ Vmax ¼ k2: E0½  ð3Þ
and after integration, the concentration of product is:
P½  ¼ k2: E0½ :t ð4Þ
The rate constant of Fe-S assembly, k2, was extracted from the slope by linear
regression of the linear portion of the curve. A similar model was applied to extract
the rate constant of persulﬁde reduction by FDX2 by monitoring Fe-S cluster
formation upon addition of FDX2 to the persulﬁdated form of the NIAU complex.
For stoichiometric conditions of reconstitution, the kinetics of persulﬁde
transfer were modelled as a ﬁrst-order reaction corresponding to the trans-
persulﬁdation reaction within the NIAU complex. The curves were ﬁtted using the
following ﬁrst-order equation:
P ¼ Pf 1 exp k:tð Þð Þ ð5Þ
Where Pf is the ﬁnal concentration of product and k the rate constant of persulﬁde
transfer.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1a, d, 2e, f, 3a, b, g–i, 4a, b, f are provided as a Source
Data ﬁle. All other data supporting the ﬁndings of this study are available from the
corresponding author on reasonable request.
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